Search

everythinglearnresearchcommunity

for

Search:↓

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Genetic factors can help predict male pattern baldness risk.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

PRP more effective than minoxidil 5% for treating alopecia areata.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Transcutol-containing vesicles improve minoxidil's skin penetration and hair growth promotion.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.